Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.4301
-0.1723 (-28.60%)
At close: May 30, 2025, 4:00 PM
0.4156
-0.0145 (-3.37%)
After-hours: May 30, 2025, 7:59 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $21.03 million as of May 30, 2025. Its market cap has decreased by -78.45% in one year.
Market Cap
21.03M
Enterprise Value
26.45M
1-Year Change
-78.45%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $21.03M, a decrease of -93.98%. That is a compound annual growth rate of -59.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 21.03M | -76.45% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.82B |
| Johnson & Johnson | 366.76B |
| AbbVie | 323.41B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.43B |
| Abbott Laboratories | 229.69B |
| Novartis AG | 219.70B |
| AstraZeneca | 216.88B |